a:5:{s:8:"template";s:4620:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta content="width=device-width" name="viewport">
<title>{{ keyword }}</title>
<style rel="stylesheet" type="text/css">a,body,div,h1,h2,html,li,span,ul{border:0;font-family:inherit;font-size:100%;font-style:inherit;font-weight:inherit;margin:0;outline:0;padding:0;vertical-align:baseline}:focus{outline:0}body{background:#fff;line-height:1}ul{list-style:none}footer,header,hgroup,nav{display:block}body{padding:0 2em}#page{margin:2em auto;max-width:1000px}#branding hgroup{margin:0 7.6%}#access div{margin:0 7.6%}body{color:#373737;font:15px "Helvetica Neue",Helvetica,Arial,sans-serif;font-weight:300;line-height:1.625}body{background:#e2e2e2}#page{background:#fff}h1,h2{clear:both}ul{margin:0 0 1.625em 2.5em}ul{list-style:square}a{color:#1982d1;text-decoration:none}a:active,a:focus,a:hover{text-decoration:underline}#branding{border-top:2px solid #bbb;padding-bottom:10px;position:relative;z-index:9999}#site-title{margin-right:270px;padding:3.65625em 0 0}#site-title a{color:#111;font-size:30px;font-weight:700;line-height:36px;text-decoration:none}#site-title a:active,#site-title a:focus,#site-title a:hover{color:#1982d1}#site-description{color:#7a7a7a;font-size:14px;margin:0 270px 3.65625em 0}#access{background:#222;background:-moz-linear-gradient(#252525,#0a0a0a);background:-o-linear-gradient(#252525,#0a0a0a);background:-webkit-gradient(linear,0 0,0 100%,from(#252525),to(#0a0a0a));background:-webkit-linear-gradient(#252525,#0a0a0a);-webkit-box-shadow:rgba(0,0,0,.4) 0 1px 2px;-moz-box-shadow:rgba(0,0,0,.4) 0 1px 2px;box-shadow:rgba(0,0,0,.4) 0 1px 2px;clear:both;display:block;float:left;margin:0 auto 6px;width:100%}#access ul{font-size:13px;list-style:none;margin:0 0 0 -.8125em;padding-left:0}#access li{float:left;position:relative}#access a{color:#eee;display:block;line-height:3.333em;padding:0 1.2125em;text-decoration:none}#access a:focus,#access li:hover>a{background:#efefef}#access a:focus,#access li:hover>a{background:#f9f9f9;background:-moz-linear-gradient(#f9f9f9,#e5e5e5);background:-o-linear-gradient(#f9f9f9,#e5e5e5);background:-webkit-gradient(linear,0 0,0 100%,from(#f9f9f9),to(#e5e5e5));background:-webkit-linear-gradient(#f9f9f9,#e5e5e5);color:#373737}#main{clear:both;padding:1.625em 0 0}#colophon{clear:both}#site-generator{background:#f9f9f9;border-top:1px solid #ddd;color:#666;font-size:12px;line-height:2.2em;padding:2.2em .5em;text-align:center}#site-generator a{color:#555;font-weight:700}@-ms-viewport{width:device-width}@viewport{width:device-width}@media (max-width:650px){body{font-size:13px}#site-title a{font-size:24px}#site-description{font-size:12px}#access ul{font-size:12px}#site-title{padding:5.30625em 0 0}#site-description,#site-title{margin-right:0}}@media only screen and (min-device-width:320px) and (max-device-width:480px){body{padding:0}#page{margin-top:0}#branding{border-top:none}}@media print{body{background:0 0!important;font-size:10pt}#page{clear:both!important;display:block!important;float:none!important;max-width:100%;position:relative!important}#branding{border-top:none!important;padding:0}#branding hgroup{margin:0}#site-title a{font-size:21pt}#site-description{font-size:10pt}#access{display:none}#main{border-top:none;box-shadow:none}#colophon{display:none}}</style>
</head>
<body class="custom-background single-author two-column left-sidebar">
<div class="hfeed" id="page">
<header id="branding" role="banner">
<hgroup>
<h1 id="site-title">{{ keyword }}<span><a href="{{ KEYWORDBYINDEX-ANCHOR 0 }}" rel="home">{{ KEYWORDBYINDEX 0 }}</a></span></h1>
<h2 id="site-description">{{ keyword }}</h2>
</hgroup>
<nav id="access" role="navigation">
<div class="menu-cap-au-large-container"><ul class="menu" id="menu-cap-au-large"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-446" id="menu-item-446"><a href="{{ KEYWORDBYINDEX-ANCHOR 1 }}">{{ KEYWORDBYINDEX 1 }}</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-321" id="menu-item-321"><a href="{{ KEYWORDBYINDEX-ANCHOR 2 }}">{{ KEYWORDBYINDEX 2 }}</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-124" id="menu-item-124"><a href="{{ KEYWORDBYINDEX-ANCHOR 3 }}">{{ KEYWORDBYINDEX 3 }}</a>
</li>
</ul></div> </nav>
</header>
<div id="main">
{{ text }}
<br>
{{ links }}
</div>
<footer id="colophon" role="contentinfo">
<div id="site-generator">
<a href="{{ KEYWORDBYINDEX-ANCHOR 4 }}" title="{{ keyword }} 2021">{{ KEYWORDBYINDEX 4 }}</a>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:8379:"800 Delaware Avenue, Wilmington, DE 19801 Highmark Health Options is an independent licensee of the Blue Cross Blue Shield Association, an association of independent Blue Cross Blue Shield Plans. Liver function abnormalities*: Ivacaftor (Kalydeco®) Lumacaftor/ivacaftor (Orkambi®) Transaminase (AST or ALT) elevations have been reported. <a href="https://mn.gov/dhs/general-public/licensing/lookup/">Information</a> <a href="https://www.england.nhs.uk/2019/10/nhs-england-concludes-wide-ranging-deal-for-cystic-fibrosis-drugs/">NHS England » NHS England concludes wide-ranging deal for ...</a> U.S. National Library of Medicine. Please click here to see the full Prescribing Information for ORKAMBI. Age 2 to 5 years weighing < 14 kg: lumacaftor 200 mg/ivacaftor 250 mg (2 packets) per day; b. 2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE PULMOZYME is indicated,in conjunction with standard therapies,for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function. Information for healthcare providers on study results from Trials 1 and 2. <a href="https://medicaid.ncdhhs.gov/media/1736/open">NC Medicaid Medicaid and Health Choice Outpatient …</a> ORKAMBI should not be used in patients other than those who have two copies of the F508del mutation in their CFTR gene. Cystic fibrosis is an inherited disease that has severe effects on the lungs and the digestive system. CAYSTON® (aztreonam for inhalation solution), for oral inhalation use Initial U.S. Approval: 1986 To reduce the development of drug-resistant bacteria and (Prescribing information: Kalydeco 2017, Orkambi 2018, Pulmozyme 2014, Symdeko 2018) Information on indications, mechanism of action, pharmacokinetics, dosing, and safety has been obtained from the prescribing information for the individual products, except where noted otherwise. DHS Licensing Information Lookup The Department of Human Services' Licensing Information Lookup is an online search tool that displays public information for all DHS-licensed programs. Figure 5.  This summary of the RMP for ORKAMBI should be read in the context of all this information including the assessment report of the evaluation and its plain-language summary, all which is part of the European Public Assessment Report (EPAR). • Utilized … <a href="https://www.dhs.pa.gov/providers/Pharmacy-Services/Documents/Drug%20List%20with%20Names/Orkambi%20lumacaftor%20ivacaftor.pdf">MEDICAL ASSISTANCE BULLETIN - PA.Gov</a> Feb 2021 - Mar 20212 months. <a href="https://www.orkambihcp.com/dosing-and-administration">Dosing and Administration</a> Orkambi can make hormonal birth control less effective, including birth control pills, injections, implants, skin patches, and vaginal rings. For Orkambi. Please click here to see the full Prescribing Information for ORKAMBI. Global Regulatory Submissions for ORKAMBI. 3. In cystic fibrosis, the secretions become thick and cause blockage. According to the manufacturer, Kalydeco and Orkambi can be dosed up to a maximum daily dose at the interval(s) as indicated in the table below. Before you take ORKAMBI, tell your doctor about all of your medical conditions, including if you: Before you take ORKAMBI, tell your doctor about all of your medical conditions, including if you: In CF patients with an FVC ≥40% of predicted, daily administration of PULMOZYMEhas also been Drug Trials Snapshots: breaking down the what, how and why. ORKAMBI is a treatment for cystic fibrosis (CF) in patients 12 years and older with two copies of a specific gene mutation called F508del.Having two copies of this mutation (one inherited from each parent) is the leading cause of CF. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction. What is the prescribing physician’s specialty? CFTR. Orkambi® (lumacaftor/ivacaftor) Orkambi® (lumacaftor/ivacaftor) may be considered medically necessary for the treatment of cystic fibrosis (CF): • In patients age 2 years and older AND • Homozygous for the F508del mutation in the CFTR gene AND • The patient does not have liver function tests (LFT) above 3X upper limit of normal (ULN) Product information on treatment with ORKAMBI, including clinical information, safety profile, and dosing and administration. Medicare’s popular prescription-drug program serves more than 42 million people and pays for more than one of every four prescriptions written nationwide. Orkambi is not approved for use by anyone younger than 2 years old. It may not always contain all the information necessary for prescribing, dispensing, or administration. Sources: www.fda.gov and Orkambi prescribing information Articles from Pharmacy and Therapeutics are provided here courtesy of MediMedia, USA frequent monitoring should be considered. and a CFTR potentiator (ivacaftor), which makes the CFTR protein at the cell surface function better because the chloride ion channel is open more often. these issues are found in the prescribing information. Aunque la fibrosis quística es progresiva y requiere cuidados médicos diarios, las personas con fibrosis quística suelen ser capaces de estudiar y trabajar. To prevent pregnancy while using Orkambi , use a barrier form of birth control: condom, diaphragm, cervical cap, or contraceptive sponge. Is the beneficiary 4 months of age or older? FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ORKAMBI is a combination of lumacaftor and ivacaftor indicated for the treatment of cystic fibrosis (CF) in … Does the beneficiary have a documented mutation in the CFTR gene that is responsive to ivacaftor? Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (primarily the G551D mutation), who account for 4–5% cases of cystic fibrosis. If request is for a dose increase, new dose does not exceed one of the following (a, b, c, or d): a. Prescriber Checkup. Please refer to the Preferred Drug List (PDL) when prescribing for our members. Orkambi 200mg/125mg tablets Orkambi 100mg/125mg tablets Orkambi 150/188mg granules Orkambi 100/125mg granules 39008, 42366, 42848, 36937 Symdeko 50mg/75mg -75 mg tablets Symdeko 100/150 mg - 150 mg tablets 44444, 46553 . Pharmaceutical form. This guide does not contain a complete list of drugs; rather, it lists the preferred drugs within the most commonly prescribed therapeutic categories. ... Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and nine development-stage product candidates. "Elexacaftor, Tezacaftor, and Ivacaftor". Learn about Vertex GPS™, a patient program for people who have been prescribed Vertex medicine. All medication-specific criteria, including drug-specific indication, age, and dose for each agent is defined in Table 1 below. NHS England has today announced it has secured a definitive agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines. Provide any pertinent medical history or information to support this off-label request. Lumacaftor/ivacaftor (Orkambi®) is indicated for the treatment of CF in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene*. Common side effects of Orkambi include sore throat and stuffy nose, nausea, diarrhea, upper respiratory tract infection, fatigue, increased blood creatine phosphokinase, rash, gas, runny nose, flu symptoms, menstrual changes, and increased blood pressure. ... herein is not sufficient to make a benefit determination or requires clarification and I agree to provide any such information to the insurer. See Important Safety Information and full Prescribing Information. Call your doctor for medical advice about side effects. ORKAMBI dose to 1 tablet daily ( lumacaftor 200 mg/ivacaftor 125 mg total daily dose) for the first week of treatment. Prior Authorization Forms . View a list of Authorized Specialty Pharmacies and Distributors for SYMDEKO®, ORKAMBI®, KALYDECO® and TRIKAFTA®. Clinical Information Requests for Kalydeco: 1. • Learned the day-to-day operations of the hospital pharmacy. Abnormalities of the eye lens (cataracts) have been reported in pediatric patients treated with ivacaftor, a component of ORKAMBI. ";s:7:"keyword";s:31:"orkambi prescribing information";s:5:"links";s:1840:"<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/clothes-size-by-height-and-weight-uk.html">Clothes Size By Height And Weight Uk</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/sarawak-population-by-race.html">Sarawak Population By Race</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/alfresco-community-edition-documentation.html">Alfresco Community Edition Documentation</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/heat-rash-healing-stages.html">Heat Rash Healing Stages</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/mommy-and-me-robe-and-swaddle-set-boy-walmart.html">Mommy And Me Robe And Swaddle Set Boy Walmart</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/sebastian-lletget-net-worth.html">Sebastian Lletget Net Worth</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/the-happiness-planner-2021.html">The Happiness Planner 2021</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/patricia-campbell-1988.html">Patricia Campbell 1988</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/abnormal-skull-growth-in-adults.html">Abnormal Skull Growth In Adults</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/nfl-color-rush-jerseys-2020.html">Nfl Color Rush Jerseys 2020</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/rash-after-pfizer-covid-vaccine.html">Rash After Pfizer Covid Vaccine</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/lakers-statement-jersey-2022.html">Lakers Statement Jersey 2022</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/fzrag/scottsdale-national-golf-club-members.html">Scottsdale National Golf Club Members</a>,
";s:7:"expired";i:-1;}